About Us
Our Experience
We offer a boutique approach to meet your endpoint and evidence development needs. With over 30 years of experience in drug and device development, our CEO, Andreas M. Pleil, PhD, can provide valuable insights and support as you consider, implement, and communicate the value that your innovation brings to patients. We focus on measurement of the patient experience with a particular expertise in pediatrics and rare diseases.
Our Approach
Our consultancy emphasizes the early planning and scientifically rigorous execution of evidence generation to meet your customers' needs without overwhelming the development process causing delays or inflating costs. We focus on fit for purpose approaches that make sense.
Why Us?
Our experience provides you access to insights that are unique in a timely and efficient manner - if you only need a few hours to help refine your strategy or a long term engagement to support your endpoint development needs, we can help.